STOCKS WITH ATTITUDE TEAM - FA/TA AND EVERYTHING ELSE Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : STOCKS WITH ATTITUDE TEAM - FA/TA AND EVERYTHING ELSE

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ivan solotaroff who wrote (838)	1/1/1998 12:05:00 PM
From: Sergio H	Read Replies (2) of 2377

Ivan, DITI looks interesting. The company, DIATIDE is waiting for fast track decision by the FDA for Acu Test, intended for use in detecting blood clots. This would be the company's first product. Decision is expected prior to March. The company has over $2/share in cash. There are 10.5 million shares but the float is only 3.6 millon. Two strong buys from analysts covering; Dillon Read and Oppenheimer. Lots of institutional and insider buying (and ownership). One insider was selling in Sept. A VP sold 5k at 7 1/2 but several institutions were buying including Equitable Co., buyer of 326k. Institutions owning shares include Merrill Lynch (8%) and Chase Manhattan (6%) Nycomed Imaging owns 14% of the company and they are DITI's principal marketing partner. Nycomed recently paid DITI a milestone fee. Sergio

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next